［1］ Reynolds AB,Kanner SB,Bouton AH,et al.SRChing for the substrates of Src［J］.Oncogene,2014,33(37):4537-4547.
[2] Zhang C,Liu LW,Sun WJ,et al.Expressions of E-cadherin,p120ctn,β-catenin and NF-κB in ulcerative colitis［J］.J Huazhong Univ Sci Technolog Med Sci,2015,35(3):368-373.
[3] Pieters T,van Hengel J,van Roy F，et al.Functions of p120ctn in development and disease［J］.Front Biosci (Landmark Ed),2012,17:760-783.
[4] Koutras C,Lessard CB,Lévesque G.A nuclear function for the presenilin 1 neuronal partner NPRAP/δ-catenin［J］.J Alzheimers Dis,2011,27(2):307-316.
[5] Ho C,Zhou J,Medina M,et al.Delta-catenin is a nervous system-specific adherens junction protein which undergoes dynamic relocalization during development［J］.J Comp Neurol,2000,420(2):261-276.
[6] Sardina JM,Walters AR,Singh KE,et al.Amelioration of the typical cognitive phenotype in a patient with the 5pter deletion associated with Cri-du-chat syndrome in addition to a partial duplication of CTNND2［J］.Am J Med Genet A,2014,164A(7):1761-1764.
[7] Lee HB,He Y,Yang GS,et al.Determination of C-terminal δ-catenin responsible for inducing dendritic morphogenesis［J］.J Nanosci Nanotechnol,2015,15(8):5589-5592.
[8] Kim H,Oh M,Lu Q,et al.E-Cadherin negatively modulates δ-catenin-induced morphological changes and RhoA activity reduction by competing with p190RhoGEF for δ-catenin［J］.Biochem Biophys Res Commun,2008,377(2):636-641.
[9] Poore CP,Sundaram JR,Pareek TK,et al.Cdk5-mediated phosphorylation of delta-catenin regulates its localization and GluR2-mediated synaptic activity［J］.J Neurosci,2010,30(25):8457-8467.
[10] Lu JP,Zhang J,Kim K，et al.Human homolog of Drosophila Hairy and enhancer of split 1,Hes1,negatively regulates δ-catenin (CTNND2) expression in cooperation with E2F1 in prostate cancer［J］.Mol Cancer,2010,9:304.
[11] Zhang H,Dai SD,Liu SL,et al.Overexpression of δ-catenin is associated with a malignant phenotype and poor prognosis in colorectal cancer［J］.Mol Med Rep,2015,12(3):4259-4265.
[12] Fang Y,Li Z,Wang X,et al.Expression and biological role of δ-catenin in human ovarian cancer［J］.J Cancer Res Clin Oncol,2012,138(10):1769-1776.
[13] Zhang JY,Wang Y,Zhang D,et al.Delta-catenin promotes malignant phenotype of non-small cell lung cancer by non-competitive binding to E-cadherin with p120ctn in cytoplasm［J］.J Pathol,2010,222(1):76-88.
[14] Zhang JY,Zhang D,Wang EH.Overexpression of small GTPases directly correlates with expression of δ-catenin and their coexpression predicts a poor clinical outcome in nonsmall cell lung cancer［J］.Mol Carcinog,2013,52(5):338-347.
[15] Ghose S,Min Y,Lin PC.δ-catenin activates Rho GTPase,promotes lymphangiogenesis and growth of tumor metastases［J］.PLoS One,2015,10(1):e0116338.
[16] Lu Q,Lanford GW,Hong H,et al.δ-catenin as a potential cancer biomarker［J］.Pathol Int,2014,64(5):243-246.
[17] Wang T,Chen YH,Hong H,et al.Increased nucleotide polymorphic changes in the 5'-untranslated region of δ-catenin (CTNND2) gene in prostate cancer［J］.Oncogene,2009,28(4):555-564.
[18] Zeng Y,Abdallah A,Lu JP,et al.δ-catenin promotes prostate cancer cell growth and progression by altering cell cycle and survival gene profiles［J］.Mol Cancer,2009,8:19.
[19] He Y,Kim H,Ryu T,et al.δ-catenin overexpression promotes angiogenic potential of CWR22Rv-1 prostate cancer cells via HIF-1α and VEGF［J］.FEBS Lett,2013,587(2):193-199.
[20] Kim H,He Y,Yang I,et al.δ-catenin promotes E-cadherin processing and activates β-catenin-mediated signaling:Implications on human prostate cancer progression［J］.Biochim Biophys Acta,2012,1822(4):509-521.
[21] Hodeib M,Serna-Gallegos T,Tewari KS.A review of HER2-targeted therapy in breast and ovarian cancer:Lessons from antiquity - CLEOPATRA and PENELOPE［J］.Future Oncol,2015,11(23):3113-3131.
[22] Bose R,Molina H,Patterson S,et al.Phosphoproteomic analysis of Her2/neu signaling and inhibition［J］.PNAS,2006,103(26):9773-9778.
[23] Zhang D,Zhang JY,Wang EH.δ-catenin promotes the malignant phenotype in breast cancer［J］.Tumor Biol,2015,36(2):569-575.
[24] Sun LH,Kang HQ,Wang X,et al.Expression of Delta-catenin protein in breast invasive ductal carcinoma and relationship between its expression and prognosis of patients［J］.China Oncol,2015,25(6):409-415.［孙丽红,康慧卿,王霞,等.Delta-catenin蛋白在乳腺浸润性导管癌中的表达及其与患者预后的关系［J］.中国癌症杂志,2015,25(6):409-415.］
[25] Tang WK,Chui CH,Fatima S,et al.Oncogenic properties of a novel gene JK-1 located in chromosome 5p and its overexpression in human esophageal squamous cell carcinoma［J］.Int J Mol Med,2007,19(6):915-923.
[26] Zhang JY,Bai CY,Bai YQ,et al.The expression of δ-catenin in esophageal squamous cell carcinoma and its correlations with prognosis of patients［J］.Hum Pathol,2014,45(10):2014-2022.